Science Advisory Board (SAB)

The SAB establishes the strategic direction and provides oversight for PDA's scientific and technical activities through the development of guidelines, technical reports, and technical bulletins and recommendations of other activities such as conferences or training courses.

Through its sister Advisory Boards, RAQAB and BioAB, the SAB, interacts with regulatory authorities by participating in the development of responses to regulatory draft and final guidance and directives.

For more information about the PDA Science Advisory Board, contact Iris Rice, Manager, S&RA Department at PDA.

PDA Science Advisory Board Members

CHAIR
John G. Shabushnig, Ph.D.
Senior Manager, Global Quality Operations
Pfizer Inc.

VICE-CHAIR
Mr. Harold S. Baseman
Chief Operating Officer and Principal
Valsource, LLP

Advisory Board Members

Raphael Bar, Ph.D.
Pharmaceutical Consultant
BR Consulting

Joyce E. Bloomfield
Executive Director, Global GMP Systems and Compliance
Merck Sharp & Dohme Corporation

Jean-Luc Clavelin
Retired
Formerly of Lilly France S.A.S.
Phil DeSantis
DeSantis Consulting Associates
Jens E. Eilertsen, Ph.D.
Senior Principal Scientist
Novo Nordisk A/S
Don E. Elinski
Senior Associate
Lachman Consultants
Kristen D. Evans
Director, Global Quality Compliance
Amgen, Inc.
Tor Gråberg
Head of Inspection
Medical products Agency
Maik W. Jornitz
Senior Vice President, Marketing & Product Management
Sartorius Stedim North America Inc.
Joachim Leube, Ph.D.
Senior Director, Quality Compliance
Crucell Holland B.V.
Michael A. Long, Ph.D.
Director and Principal Consultant
Concordia ValSource
Russell E. Madsen
President
The Williamsburg Group, LLC
Walter De Matteo
Manager, Microbiological Laboratory
Lily France S.A.S.
Grace E. McNally
Consumer Safety Officer, CDER
United States Food and Drug Administration
Jeanne E. Moldenhauer, Ph.D.
Vice President
Excellent Pharma Consulting
Christopher J. Smalley, Ph.D.
Associate Director, BioSterile Validation
Merck & Co., Inc.
Brenda W. Uratani, Ph.D.
CGMP Compliance Officer
United States Food and Drug Administration
Glenn E. Wright
Senior Director, Project Management
Eli Lilly and Company
PDA Staff Liaison
Richard V. Levy, Ph.D.
Senior Vice President, Scientific & Regulatory Affairs
PDA Global Headquarters
Georg Roessling, Ph.D.
Senior Vice President, European Operations
PDA Europe
Iris D. Rice
Manager, Scientific & Regulatory Affairs
PDA Global Headquarters
 

From: 
Email:  
To: 
Email:  
Subject: 
Message: